Vaccine Effective Against Delta Variant Of Coronavirus: US Study.

Vaccine Effective Against Delta Variant Of Coronavirus: US Study

Moderna was 95 per cent effective at preventing hospitalisations among aged 18 and older.

Washington:

COVID-19 vaccines are effective at preventing hospitalisations and emergency department visits caused by the Delta variant of the SARS-CoV-2 virus, according to a US study.

The research that used national data also indicates that Moderna's vaccine is significantly more effective against Delta variant than Pfizer and Johnson & Johnson preventives.

"These real-world data show that vaccines remain highly effective at reducing COVID-19 related hospitalisations and emergency department visits, even in the presence of the new COVID-19 variant," said study author Shaun Grannis, vice president for data and analytics at Regenstrief Institute in the US.

"We strongly recommend vaccinations for all who are eligible to reduce serious illness and ease the burden on our healthcare system," Grannis said in a statement.

The authors noted that the Centers for Disease Control and Prevention (CDC)'s VISION Network has analysed more than 32,000 medical encounters from nine states during June, July and August 2021, when the Delta variant became the predominant strain.

The results showed that unvaccinated individuals with COVID-19 are 5-7 times more likely to need emergency department care or hospitalisation, similar to the overall effectiveness prior to the variant, they said.

The study in Morbidity and Mortality Weekly Report, a weekly epidemiological digest for the US published by CDC, is also the first analysis from the VISION Network to show a marked difference between the effectiveness of the mRNA vaccines.

In the study's time period, Moderna was 95 per cent effective at preventing hospitalisations among adults aged 18 and older, the authors said.

The Pfizer vaccine was 80 per cent effective while the Johnson & Johnson preventive was 60 per cent effective at preventing hospitalisations among adults ages 18 and older, they said.

The study also found that vaccine effectiveness is lower for people 75 years and older, which has not been shown in previous research.

The researchers explained that this could be due to a range of factors, including the increased time since vaccination.

When it came to preventing emergency department and urgent care visits, analysis showed that Moderna was 92 per cent effective, Pfizer was 77 per cent effective, while Johnson & Johnson was 65 per cent effective.

"Despite the differences in effectiveness, vaccines continue to offer much more protection than not getting one at all," said Grannis, who is also a professor at Indiana University School of Medicine, US.

"While breakthrough cases do happen, data shows the symptoms are less severe, he said.

The authors of the study noted that a vast majority of COVID hospitalisations and deaths continue to be among unvaccinated individuals.

They added that COVID-19 vaccines are powerful tools for combating the pandemic.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Related news

All-Civilian Crew «Healthy, Happy And Resting» : SpaceX.

SpaceX's all-civilian Inspiration4 crew are "healthy, happy and resting comfortably," the company said Thursday in its first update since the pioneering mission blasted off from Cape Canaveral the...

NDTV News

Larry Elder: The lines to vote are long, that's good news.

Larry Elder: The lines to vote are long, that's good news.

California gubernatorial candidate discusses the recall election on 'Hannity' #FoxNews #Hannity Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news service delive...

Analyzing California's governor recall election

Analyzing California's governor recall election

California voters headed to the polls on Tuesday to decide if Democratic Governor Gavin Newsom should remain in office. CBS News chief Washington correspondent Major Garrett, Washington reporter Dave Weigel and Orange County Register reporter Broo...

Understanding the constitutionality of California's recall vote.

Understanding the constitutionality of California's recall vote.

The recall vote has often been a matter of debate in this country. CBS News legal contributor Jessica Levinson joins CBSN's "Red & Blue" host Elaine Quijano and CBS News senior White House and political correspondent Ed O'Keefe about why Californi...

Local Matters: How the California recall is impacting state politics.

Local Matters: How the California recall is impacting state politics.

The special election to recall California Governor Gavin Newsom may have bigger implications on the future of the state's politics. He still faces the general gubernatorial election in November 2022. Dustin Gardiner, state politics reporter for th...

California congresswoman ‘hopeful’ Newsom survives recall challenge.

California congresswoman ‘hopeful’ Newsom survives recall challenge.

Rep. Karen Bass, D-Calif., weighs in on the California recall election, and the latest on congressional debates on spending, criminal justice and voting reform. ABC News Live Prime, Weekdays at 7EST & 9EST WATCH the ABC News Live Stream Here: SUBS...

Does being high on marijuana help athletes perform better?.

Does being high on marijuana help athletes perform better?.

ABC News' Linsey Davis speaks with Josiah Hesse, author of the new book “Runner's High: How a Movement of Cannabis-Fueled Athletes Is Changing the Science of Sports.” ABC News Live Prime, Weekdays at 7EST & 9EST WATCH the ABC News Live Stream Here...